Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm
Provided By PR Newswire
Last update: Sep 19, 2025
NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) breached their fiduciary duties to shareholders.
Read more at prnewswire.com
